PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
27-Sep-2024 Inflammatory Bowel Disease Treatment Market to Hit USD 38.2 Billion in 2032 Global Market Insights, Inc.
27-Sep-2024 SOLARIO study meets its primary endpoints - Bone substitute with local antibiotics enables reduced systemic antibiotic treatment SOLARIO
27-Sep-2024 Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib) Pharming Group N.V.
27-Sep-2024 Diabetic Gastroparesis Treatment Market: Rising Demand Sparks Innovation and Research Pristine Market Insights
27-Sep-2024 SmartHMS Revolutionizes Healthcare Management with Its Advanced SMARTHMIS Software SMARTHMS & Solutions Private Limited
26-Sep-2024 Concern over school and university starters as immunity levels fall below WHO’s recommendations London Medical Laboratory
26-Sep-2024 Audiological Devices Market Dynamics: Trends, Challenges and Growth Opportunities in the Coming Decade Pristine Market Insights
25-Sep-2024 New data show Almirall´s EBGLYSS® (lebrikizumab) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis Almirall
25-Sep-2024 Arctoris announces strategic partnership with Alphabet company, Isomorphic Labs Arctoris
25-Sep-2024 Combination treatment improves response to immunotherapy for lung cancer Francis Crick Institute
25-Sep-2024 Explosive Growth in 3D Imaging Market Driven by Advancements in Healthcare and Industrial Applications Acumen Research And Consulting
24-Sep-2024 InnoScot Health's new webinar encourages healthcare innovators to look ‘beyond the idea’ InnoScot Health
24-Sep-2024 Digital Therapeutics Market To Witness Explosive Growth of Around 29% CAGR from 2023 to 2032 Driven By Widespread Adoption of Digital Health Solutions Acumen Research And Consulting
23-Sep-2024 Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine Vicebio Ltd
23-Sep-2024 DARZALEX® (daratumumab)-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma Janssen-Cilag
23-Sep-2024 Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering Zenas BioPharma
23-Sep-2024 2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA Association of the British Pharmaceutical Industry (ABPI)
23-Sep-2024 Terumo Blood and Cell Technologies collaborates with Nova Biomedical to bring automated cell culture sensing to Quantum Flex Terumo Blood and Cell Technologies
23-Sep-2024 Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer Theriva™ Biologics, Inc.
23-Sep-2024 Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia Teva Pharmaceutical Industries Ltd